[1]郭建全.曲安奈德对年龄相关性白内障术后前葡萄膜炎的疗效及其对炎症因子的影响[J].眼科新进展,2014,34(8):769-771.[doi:10.13389/j.cnki.rao.2014.0212]
 GUO Jian-Quan.Efficacy of triamcinolone acetonide for anterior uveitis after age-related cataract surgery and its impact on inflammatory cytokines[J].Recent Advances in Ophthalmology,2014,34(8):769-771.[doi:10.13389/j.cnki.rao.2014.0212]
点击复制

曲安奈德对年龄相关性白内障术后前葡萄膜炎的疗效及其对炎症因子的影响
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
34卷
期数:
2014年8期
页码:
769-771
栏目:
应用研究
出版日期:
2014-08-05

文章信息/Info

Title:
Efficacy of triamcinolone acetonide for anterior uveitis after age-related cataract surgery and its impact on inflammatory cytokines
作者:
郭建全
江苏省张家港市,张家港市中医医院眼科
Author(s):
GUO Jian-Quan
关键词:
曲安奈德白内障葡萄膜炎炎性因子
Keywords:
triamcinolone acetonide cataract uveitis inflammatory cytokines
DOI:
10.13389/j.cnki.rao.2014.0212
文献标志码:
A
摘要:
目的 观察曲安奈德对年龄相关性白内障术后前葡萄膜炎的临床疗效及其对相关炎症因子的影响。方法 选择2010年2月至2012年6月间我科收治的年龄相关性白内障患者168例(168眼)为研究对象,按照治疗方式的不同分为对照组和曲安奈德组,每组各84例(84眼)。对照组予以术后结膜下注射地塞米松,而曲安奈德组给予前房注射2mg曲安奈德,对比两组患者术后第1天、第3天和第5天的最佳矫正视力、眼压、前房细胞数、房水闪辉情况,并于术后第5天测肿瘤坏死因子-α(tumornecrosisfactor-α,TNF-α)、干扰素-γ(interferon-γ,IFN-γ)和白细胞介素-10(interleukin-10,IL-10)的含量变化。结果 曲安奈德组患者的最佳矫正视力在术后第3天已有明显改善,显著优于对照组(P<0.05)。且两组间前房细胞数及房水闪辉比较发现,术后第3天和第5天,两组差异均具有统计学意义(均为P<0.05)。术后第5天曲安奈德组的TNF-α和IFN-γ的表达水平分别为(19.6±8.9)pg?L-1、(14.4±7.8)pg?L-1,显著低于对照组(29.5±14.2)pg?L-1、(39.8±10.3)pg?L-1,差异均有统计学意义(均为P<0.05),而IL-10含量两组间比较差异却无统计学意义(P>0.05)。结论 年龄相关性白内障手术中前房注射曲安奈德可有效抑制术后前葡萄膜炎,减少前房反应,且抗炎效果良好。
Abstract:
Objective To observe the clinical efficacy of triamcinolone acetonide for anterior uveitis after age-related cataract surgery and its impact on associated inflammatory cytokines. Methods A total of 168 age-related cataract patients ( 168 eyes)from February 2010 to June 2012 in our hospital were divided into conventional treatment control group and triamcinolone acetonide group according to the different treatment,84 cases ( 84 eyes ) in each group. Control group received postoperative sub-conjunctival injection of dexamethasone . and anterior chamber injection of triamcinolone acetonide group was given 2 mg triamcinolone acetonide. Best corrected visual acuity,intraocular pressure, anterior chamber cells and aqueous flare at pre-operation and postoperative I day,3 days and 5 days , and TNF-e/ ,IFN-7 and IL-IO were detected at postoperative 5 days. Results Best corrected visual acuity in triamcinolone acetonide group at postoperative 3 days obviously improved , significantly better than that of control group (P < 0. 05 ) . There were statistical differences in number of anterior chamber cells and aqueous flare at postoperative 3 days and 5 days between two groups ( all P < 0. 05 ) . TNF-ce and IFN-7 levels in triamcinolone acetonide group at postoperative 5 days were ( 19. 6 + 8. 9) pg . L-l and ( 14. 4 + 7. 8) pg . L’l , respectively , which in conventional treatment control group were (29. 5 + 14. 2) pg . L-1 and ( 39. 8 + 10. 3) pg . L’] , respectively, there were statistical difference ( all P < 0. 05 ) ,but there was no statistical difference in IL-IO between two groups (P > 0. 05 ) . Conclusion During age-related cataract surgery , injection of triamcinolone acetonide into anterior chamber can effectively inhibit postoperative anterior uveitis and anterior chamber reaction with better anti-inflammatory effects.

相似文献/References:

[1]乔建治 张永喜.抗青光眼术后白内障行不同切口超声乳化术的临床疗效分析[J].眼科新进展,2012,32(4):000.
[2]麻南 李丹 高付林 胡莲娜.玻璃体内注射贝伐单抗和贝伐单抗/曲安奈德联合用药治疗糖尿病性黄斑水肿疗效及安全性差异的荟萃分析[J].眼科新进展,2012,32(6):000.
[3]徐冰 董宁 肖林 褚利群 徐景美 王冰松.不同剂量曲安奈德前房注射抑制青光眼联合白内障手术后前葡萄膜炎的临床研究[J].眼科新进展,2012,32(6):000.
[4]吴星.年龄相关性白内障患者超声乳化手术前后对比敏感度分析[J].眼科新进展,2012,32(6):000.
[5]王勇 叶应嘉 鲍先议 周龑丽 许荣 彭婷婷 曾志富.同轴微小切口超声乳化吸出术在青光眼滤过术后白内障摘出术中的应用[J].眼科新进展,2012,32(7):000.
[6]徐威.注射器针头囊袋内吸附劈核法在白内障手术中的应用[J].眼科新进展,2012,32(7):000.
[7]冉文瑛 陈静 张树利.抗青光眼术后不同角膜切口白内障超声乳化术对角膜屈光状态的影响[J].眼科新进展,2012,32(7):000.
[8]王运.常规连续模式超声乳化术与爆破模式冷超声乳化术治疗白内障的临床疗效比较[J].眼科新进展,2012,32(11):000.
[9]林鹏耀 王康 李娜 于书静 李茜 李爽 李铭明.视网膜光凝术后Tenon囊下注射曲安奈德对糖尿病大鼠视网膜厚度的影响[J].眼科新进展,2012,32(12):000.
[10]郭照洪 王宏 宋爱平 文译 侯祺 解柳.超声乳化白内障摘出联合人工晶状体植入治疗超高度轴性近视白内障患者的临床疗效[J].眼科新进展,2013,33(1):000.

更新日期/Last Update: 2014-07-30